Financial PerformanceSYK delivered strong diversified results in 3Q24, with revenue significantly exceeding analyst and market expectations.
Market PositionStryker enjoys market-leading positions in the $41B orthopedic market, the $31B MedSurg, and the $8B neurovascular market.
Product LaunchesSYK's ongoing super cycle of key product launches across the portfolio is anticipated to be a material tailwind for the company through at least the remainder of 2024 and 2025.